Dimethyl thiocarbamic acid S-(4-bromo-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)ester | 256222-50-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: Dimethyl thiocarbamic acid S-(4-bromo-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)ester
• 英文别名: S-[(4-bromo-6,6-dimethyl-8-oxo-5,7-dihydronaphthalen-1-yl)] N,N-dimethylcarbamothioate
• CAS: 256222-50-1
• 化学式: C₁₅H₁₈BrNO₂S
• 分子量: 356.283
• InChiKey: SSWGAWZENYSDQO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  62.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Dimethyl thiocarbamic acid S-(4-bromo-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)ester 在 氢氧化钾 作用下， 以 甲醇 为溶剂， 生成
  参考文献：
  名称：

  3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of α5-containing GABAA receptors

  摘要：

  A series of substituted 3,4-dihydronaphthalen-1(2H)-ones with high binding affinity for the benzodiazepine site of GABA(A) receptors containing the alpha5-subunit has been identified. These compounds have consistently higher binding affinity for the GABA(A) alpha5 receptor subtype over the other benzodiazepine-sensitive GABA(A) receptor subtypes (alpha1, alpha2 and alpha3). Compounds with a range of efficacies for the benzodiazepine site of alpha5-containing GABA(A) receptors were identified, including the alpha5 inverse agonist 3,3-dimethyl-8-methylthio-5-(pyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 22 and the alpha5 agonist 8-ethylthio-3-methyl-5-(1-oxidopyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 19. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.054
• 作为产物：
  描述：

  5-bromo-3,3-dimethyl-8-methoxy-3,4-dihydronaphthalen-1(2H)-one 在 三乙烯二胺 、 三溴化硼 、 N,N-二甲基苯胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 Dimethyl thiocarbamic acid S-(4-bromo-6,6-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)ester
  参考文献：
  名称：

  3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of α5-containing GABAA receptors

  摘要：

  A series of substituted 3,4-dihydronaphthalen-1(2H)-ones with high binding affinity for the benzodiazepine site of GABA(A) receptors containing the alpha5-subunit has been identified. These compounds have consistently higher binding affinity for the GABA(A) alpha5 receptor subtype over the other benzodiazepine-sensitive GABA(A) receptor subtypes (alpha1, alpha2 and alpha3). Compounds with a range of efficacies for the benzodiazepine site of alpha5-containing GABA(A) receptors were identified, including the alpha5 inverse agonist 3,3-dimethyl-8-methylthio-5-(pyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 22 and the alpha5 agonist 8-ethylthio-3-methyl-5-(1-oxidopyridin-2-yl)-3,4-dihydronaphthalen-1(2H)-one 19. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.054

文献信息

• Substituted tetralone derivatives for enhancing cognition
  申请人：Merck Sharpe & Dohme Limited

  公开号：US06156761A1

  公开（公告）日：2000-12-05

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein A, B, R2, R3 and q are as defined in the disclosure, pharmaceutical compositions containing them; methods for their production; their use in therapy and methods of treatment of disease states where cognition enhancement is required, such as Alzheimer's disease.

  本发明提供了化合物的结构式（I）或其药学上可接受的盐：##STR1##其中A、B、R2、R3和q的定义如披露中所述，含有它们的药物组合物；它们的生产方法；它们在治疗中的使用以及治疗需要认知增强的疾病状态的方法，如阿尔茨海默病。